secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001104659-26-057974
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte receives Nasdaq deficiency notice for bid price below $1.00; 180 days to comply
--------------------------------------------------------------------------------

- Received Nasdaq letter on May 4, 2026, for bid price below $1.00 for 30 consecutive business days through May 1, 2026.
- Must regain compliance by Nov 2, 2026, by having closing bid price ≥ $1.00 for at least 10 consecutive business days.
- No immediate effect on listing; common stock continues to trade on Nasdaq under symbol HUMA.
- Company intends to monitor bid price and evaluate available options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465926057974/0001104659-26-057974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465926057974/tm2614071d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-057974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer